JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
XLO Financials - Xilio Therapeutics Income & Cash Flow | Ledgeburg
XLO - Xilio Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary XLO Stock
Financials
Financials XLO Stock
Loading...
Loading...
Income Statement
Income Statement XLO Stock
Balance Sheet
Balance Sheet XLO Stock
Cash Flow Statement
Cash Flow Statement XLO Stock
Loading...
Loading...
Home
Stocks
Xilio Therapeutics, Inc. (XLO)
Financials
Financials of XLO
Loading...
Loading...
Loading...
Loading...
Revenue
$43.766M
Operating Income
$-41.982M
Net Income
$-35.036M
Share Count (Basic)
8.359109M
Operating Cash Flow
$-4.992M
Free Cash Flow
$-5.51M
Cash And Short-Term Equivalents
$137.531M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
10M
20M
30M
40M
FY2024
FY2025
Revenue $USD
0
5M
10M
15M
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-90M
-80M
-70M
-60M
-50M
-40M
Annual
Quarterly
Margins
Gross
Operating
Net
-1000%
-800%
-600%
-400%
-200%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-10M
0
10M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-400%
-200%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26